HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma.

Abstract
Extra-nodal natural killer T-Cell (NK/T-cell) lymphoma is a progressive cancer with poor prognosis due to the lack of disease specific treatment. To develop specific therapeutic strategies, it is essential to identify tumor markers. Recent studies show that circulating microRNA (miRNA) may serve as diagnostic and/or prognostic markers for some diseases. To explore miRNAs as potential diagnostic and/or prognostic markers of NK/T-cell lymphoma, in our study, we compared circulating miR-221 levels in 79 patients and 37 normal subjects by real-time PCR amplification directly from plasma samples, and correlated patient's miR-221 levels with their clinic features and treatment outcomes. We observed a significant difference between the patient and control groups (p=0.038), and a correlation of plasma miR-221 level in patient with sex, as well as a reverse correlation with performance status and the overall survival after treatment. Univariate and multivariate analyses further revealed that plasma miR-221 level, age, B symptoms, LDH level and complete response after primary treatment all present prognostic values when judged by overall survival (OS). Together, our results show that it is feasible to perform direct amplification of plasma miRNAs without total RNA extraction, and plasma miR-221 may be a diagnostic and prognostic marker for NK/T-cell lymphoma.
AuthorsHong-Qiang Guo, Guo-Liang Huang, Cheng-Cheng Guo, Xing-Xiang Pu, Tong-Yu Lin
JournalDisease markers (Dis Markers) Vol. 29 Issue 5 Pg. 251-8 ( 2010) ISSN: 1875-8630 [Electronic] United States
PMID21206010 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Biomarkers, Tumor
  • MIRN221 microRNA, human
  • MicroRNAs
  • Doxorubicin
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibiotics, Antineoplastic (therapeutic use)
  • Biomarkers, Tumor (blood)
  • Case-Control Studies
  • Doxorubicin (therapeutic use)
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms (diagnosis, drug therapy, mortality)
  • Humans
  • Lymphoma, Extranodal NK-T-Cell (diagnosis, drug therapy, mortality)
  • Male
  • MicroRNAs (blood)
  • Middle Aged
  • Prognosis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: